Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M232Revenue $M1.9Net Margin (%)-2,469.5Z-Score-7.5
Enterprise Value $M227EPS $-1.6Operating Margin %-1,837.8F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-2,469.5Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio10.1Cash flow > EarningsY
Price/Sales47.85-y EBITDA Growth Rate %-37.7Current Ratio10.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-235.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.3ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 56.

No Entry found!

ALIM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holland DavidSVP of Sales & Marketing 2014-07-01Sell5,000$6.02-3.65 view
BAVP, L.P.10% Owner 2014-06-30Sell600$6.25-7.2 view
Myers C. DanielPresident and CEO 2014-06-06Sell5,000$5.564.32 view
Holland DavidSenior Vice President of Sales 2014-06-02Sell5,000$5.731.22 view
Holland DavidSVP of Sales and Marketing 2014-05-01Sell5,000$5.93-2.19 view
BAVP, L.P.10% Owner 2014-04-24Sell196,369$6.56-11.59 view
Holland DavidSVP of Sales and Marketing 2014-04-01Sell10,000$8.01-27.59 view
Caballa SusanSee Remarks 2014-03-04Sell8,931$7.01-17.26 view
Myers C. DanielPresident and CEO 2014-03-04Sell22,775$7.1-18.31 view
Holland DavidSVP of Sales and Marketing 2014-03-04Sell10,000$6.84-15.2 view

Press Releases about ALIM :

    Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    comment on ALIM Mar 02 2013 
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    Alimera Sciences To Release Second Quarter 2014 Results Jul 24 2014
    Alimera Sciences To Release Second Quarter 2014 Results Jul 24 2014
    ALIMERA SCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 30 2014
    pSivida moves to marketing authorization national phase in 10 more EU countries Jun 30 2014
    Alimera Sciences' ILUVIEN® Receives Positive Outcome Of Repeat-Use Procedure For 10 Additional... Jun 30 2014
    Alimera Sciences's Iluvien reecives marketing authorization in Italy Jun 23 2014
    Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Italy For The Treatment Of Chronic... Jun 23 2014
    ALIMERA SCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 09 2014
    pSivida: Incredible Upside Potential With Limited Risk Jun 09 2014
    Alimera Sciences To Present At Jefferies Healthcare Conference May 27 2014
    ALIMERA SCIENCES INC Files SEC form 8-K, Material Modification to Rights of Security Holders,... May 16 2014
    SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Alimera... May 16 2014
    ALIMERA SCIENCES INC Financials May 16 2014
    Alimera Sciences reports Q1 EPS (20c), consensus (25c) May 08 2014
    Alimera Sciences (ALIM) Q1 2014 Results - Earnings Call Webcast May 08 2014
    ALIMERA SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 08 2014
    Alimera Sciences Reports First Quarter 2014 Financial Results May 08 2014
    Q1 2014 Alimera Sciences Inc Earnings Release - After Market Close May 08 2014
    Alimera Sciences To Release First Quarter 2014 Results May 01 2014
    Specialised Therapeutics Australia To License New Drug - Iluvien(R) - To Improve Vision in Patients... Apr 28 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide